SCHEMBL25856889

SCHEMBL25856889

CCCC1(CCC)CC(=O)c2cc(-c3cc(-c4cccnc4)no3)ccc2O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 13/20 0.41
▸ CYP2C19 P33261 13/20 0.41
▸ CYP3A4 P08684 12/20 0.41
▸ CYP1A2 P05177 9/20 0.41
▸ CYP2D6 P10635 9/20 0.41
▸ CYP2E1 P05181 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ GLA P06280 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ CASP1 P29466 2/20 0.37
▸ CASP7 P55210 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ S1PR1 P21453 1/20 0.35
▸ ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23523954 0.86 MAPT (0.49) KDM4EALDH1A1HPGDHSD17B10S1PR1
SCHEMBL23558461 0.82 NPC1 (0.45) CYP2C9CYP2C19CYP3A4CYP1A2HPGD
SCHEMBL25856971 0.81 KDM4E (0.47) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL23524236 0.80 NPC1 (0.51) KDM4EALDH1A1HPGDHSD17B10S1PR1
SCHEMBL25856900 0.78 MAOB (0.43) KDM4EGAATP53MAPT
SCHEMBL23084682 0.78 MAPT (0.51) KDM4EALDH1A1HPGDHSD17B10S1PR1
SCHEMBL30355722 0.78 NPC1 (0.49) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL30355619 0.78 MAPT (0.51) KDM4EALDH1A1HPGDHSD17B10S1PR1
SCHEMBL23524239 0.78 NPC1 (0.49) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6
SCHEMBL23558442 0.77 S1PR1 (0.42) CYP2C9CYP2C19CYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 CYP2C9 4770/4885CYP2C19 4354/4885CYP3A4 4104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback